Canadian Medical and Surgical Knowledge Translation Research Group

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Circulating Vascular Regenerative Cell Exhaustion in Individuals Without Type 2 Diabetes Who Are of South Asian or European Origins

Not yet recruiting

Conditions: Cardiovascular Diseases Risk

First Posted Date: 2025-01-10

Last Posted Date: 2025-01-10

Lead Sponsor: Canadian Medical and Surgical Knowledge Translation Research Group

Target Recruit Count: 120

Registration Number: NCT06769347

Vascular Regenerative Cell Exhaustion in Adults with Peripheral Artery Disease (PAD-VRCE)

Recruiting

Conditions: Peripheral Vascular Diseases
Cardiovascular Disease
Type 2 Diabetes
Peripheral Artery Disease

First Posted Date: 2024-10-04

Last Posted Date: 2024-10-04

Lead Sponsor: Canadian Medical and Surgical Knowledge Translation Research Group

Target Recruit Count: 40

Registration Number: NCT06626646

Locations: 🇨🇦
North York Diagnostic and Cardiac Centre, North York, Ontario, Canada
🇨🇦
Diagnostic Assessment Centre, Scarborough, Ontario, Canada

Lipoprotein (a) and Vascular Regenerative Cell Content

Recruiting

Conditions: Cardiovascular Diseases
Atherosclerosis Cardiovascular Disease
Ischemic Heart Disease
Dyslipidemia

First Posted Date: 2024-10-04

Last Posted Date: 2024-10-04

Lead Sponsor: Canadian Medical and Surgical Knowledge Translation Research Group

Target Recruit Count: 40

Registration Number: NCT06626659

Locations: 🇨🇦
North York Diagnostic and Cardiac Centre, North York, Ontario, Canada
🇨🇦
Diagnostic Assessment Centre, Scarborough, Ontario, Canada

Functional Investigation of Endothelial Function and Regenerative Cell Exhaustion

Not yet recruiting

Conditions: Diabetes Mellitus, Type 2

First Posted Date: 2023-10-31

Last Posted Date: 2023-11-13

Lead Sponsor: Canadian Medical and Surgical Knowledge Translation Research Group

Target Recruit Count: 90

Registration Number: NCT06108388

Locations: 🇨🇦
Diagnostic Assessment Centre, Scarborough, Ontario, Canada

Semaglutide and Vascular Regeneration

Phase 4

Recruiting

Conditions: Cardiovascular Diseases
Atherosclerosis
Diabetes Mellitus, Type 2
Obesity

Interventions: Drug: Semaglutide Pen Injector

First Posted Date: 2023-05-23

Last Posted Date: 2023-07-25

Lead Sponsor: Canadian Medical and Surgical Knowledge Translation Research Group

Target Recruit Count: 100

Registration Number: NCT05870462

Locations: 🇨🇦
Diagnostic Assessment Centre, Scarborough, Ontario, Canada
🇨🇦
North York Diagnostic and Cardiac Centre, North York, Ontario, Canada

Pro-vascular Regenerative Cell Exhaustion in Women With Polycystic Ovarian Syndrome

Conditions: Polycystic Ovary Syndrome

First Posted Date: 2022-06-08

Last Posted Date: 2022-06-08

Lead Sponsor: Canadian Medical and Surgical Knowledge Translation Research Group

Target Recruit Count: 30

Registration Number: NCT05410834

Locations: 🇨🇦
Langstaff Medical Centre, Woodbridge, Ontario, Canada
🇨🇦
Centrum Services Newmarket, Newmarket, Ontario, Canada
🇨🇦
Diagnostic Assessment Centre, Scarborough, Ontario, Canada

Generalizability of REDUCE-IT Results to People of South Asian Descent With Atherosclerotic Cardiovascular Disease in Canada (REDUCE-IT Canada SA)

Completed

Conditions: Cardiovascular Diseases
Coronary Heart Disease
Myocardial Infarction
Atherosclerotic Cardiovascular Disease

First Posted Date: 2022-03-09

Last Posted Date: 2023-03-27

Lead Sponsor: Canadian Medical and Surgical Knowledge Translation Research Group

Target Recruit Count: 200

Registration Number: NCT05271591

Locations: 🇨🇦
Scarborough Health Network, Ajax, Ontario, Canada
🇨🇦
Fenton Medical Centre, Markham, Ontario, Canada
🇨🇦
North York Diagnostic and Cardiac Centre, North York, Ontario, Canada

and more 2 locations

The Role of South Asian vs European Origins on Circulating Regenerative Cell Exhaustion

Completed

Conditions: Diabetes
Type 2 Diabetes
Ischemic Heart Disease
Ischemic Stroke
Peripheral Vascular Diseases
Type 1 Diabetes
Cardiovascular Diseases

First Posted Date: 2022-02-23

Last Posted Date: 2023-02-09

Lead Sponsor: Canadian Medical and Surgical Knowledge Translation Research Group

Target Recruit Count: 120

Registration Number: NCT05253521

Locations: 🇨🇦
Markham HealthPlex Medical Centre, Markham, Ontario, Canada
🇨🇦
North York Diagnostic and Cardiac Centre, North York, Ontario, Canada
🇨🇦
Diagnostic Assessment Centre, Scarborough, Ontario, Canada

The Use of Icosapent Ethyl on Vascular Progenitor Cells in Individuals With Elevated Cardiovascular Risk

Phase 4

Completed

Conditions: Cardiovascular Diseases
Cardiovascular Risk Factor
Triglycerides High
Diabetes Mellitus, Type 2

Interventions: Drug: Icosapent Ethyl 1000 MG Oral Capsule [Vascepa]

First Posted Date: 2020-09-24

Last Posted Date: 2024-04-02

Lead Sponsor: Canadian Medical and Surgical Knowledge Translation Research Group

Target Recruit Count: 70

Registration Number: NCT04562467

Locations: 🇨🇦
The Oshawa Clinic, Oshawa, Ontario, Canada
🇨🇦
Diagnostic Assessment Centre, Scarborough, Ontario, Canada
🇨🇦
Langstaff Medical Clinic, Vaughan, Ontario, Canada

A Study of Evolocumab on Carotid Artery Atherosclerotic Plaque Morphology Prior to Carotid EndArterectomy

Phase 4

Conditions: Carotid Artery Stenosis
Asymptomatic Carotid Artery Stenosis

Interventions: Drug: Evolocumab

First Posted Date: 2020-09-04

Last Posted Date: 2022-05-02

Lead Sponsor: Canadian Medical and Surgical Knowledge Translation Research Group

Target Recruit Count: 60

Registration Number: NCT04539223

Locations: 🇨🇦
North York Diagnostic and Cardiac Centre, North York, Ontario, Canada
🇨🇦
St. Michael's Hospital, Toronto, Ontario, Canada
🇨🇦
East Toronto Vascular Clinic, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy